Evaluating Treatment Efficacy
At MARS, we provide both sensitive cognitive assessments and repeated testing.
Since the 1990s, several drugs that may slow the progression of Alzheimer's Disease and other dementias have been developed. Fortunately, drugs continue to be developed that can potentially alter the course of dementias and/or increase brain functioning under different circumstances.
MARS has the capability to assess the effectiveness of drugs proposing to affect brain functioning in both individuals and groups. The assessment of the effectiveness of these drugs requires both sensitive cognitive assessments and repeated testing. At MARS, we provide:
-
a comprehensive cognitive assessment using the best clinical tools available
-
repeated assessment
-
statistical services to evaluate the effects of drugs on these tests
-
report writing services to present results in an easy to understand, yet accurate format
In addition to using the best available clinical assessments, MARS can develop cognitive assessments tailored to assess the cognitive effects of particular drugs.
One service particularly useful for an individual on cognitive enhancing drugs is the continued monitoring of the drugs' effectiveness. This information can aid physicians in making more effective decisions about drug use and dosages.
Evaluating Treatment Efficacy
